GGrantIndex
Sort

166,118 grants matching stem cells

Base editing and prime editing for sickle cell disease

$733,558
Mitchell J Weiss · St. Jude Children'S Research Hospital · R01 · FY2021 · HL

ID3 regulation of tissue-infiltrating T cells mediating graft-versus-host disease and leukemia rejection

$733,555
Yi Zhang · Hackensack University Medical Center · R01 · FY2025 · CA

Core G: Biomarker Core

$733,533
Aimee Kao · University Of California, San Francisco · P30 · FY2021 · AG

Calcium as a Molecular Signal in the Heart

$733,515
Steven R Houser · Temple Univ Of The Commonwealth · R01 · FY2008 · HL

Calcium as a Molecular Signal in the Heart

$733,515
Steven R Houser · Temple Univ Of The Commonwealth · R01 · FY2009 · HL

Sending and transducing Hedgehog and Wnt signals

$733,494
Adrian Salic · Harvard Medical School · R35 · FY2025 · GM

Investigating the role of KAT6A in MLL-rearranged acute myeloid leukemia

$733,489
Mario Andres Blanco · University Of Pennsylvania · R01 · FY2025 · CA

OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation

$733,453
Evan Dale Abel · University Of California Los Angeles · R33 · FY2022 · HL

Sexually Dimorphic Mechanisms in Human Thoracic Aortic Aneurysm.

$733,439
Dogukan Mizrak · University Of Michigan At Ann Arbor · R01 · FY2025 · HL

Molecular mechanisms linking the CXCL12 pathway to atherosclerosis

$733,396
Danish Saleheen · University Of Pennsylvania · R01 · FY2016 · HL

Defining Genetic Architecture and Pathways of DCM

$733,383
Jonathan G Seidman · Harvard Medical School · R01 · FY2024 · HL

MicroRNA Control of Dilated Cardiomyopathy

$733,369
Mark Mercola · Stanford University · R01 · FY2019 · HL

Foamy Virus Mediated gene Therapy in the Canine SCID-X1 model

$733,318
Hans-Peter Kiem · Seattle Children'S Hospital · P01 · FY2015 · AI

Genetically altered mice to study ocular function and pathology

$733,301
Eric Wawrousek · National Eye Institute · Z01 · FY2008 · EY

Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approaches

$733,301
Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2020 · OD

Depletion, Repopulation and Tolerance in Non-Sensitied Recipients

$733,286
Allan D. Kirk · Duke University · U19 · FY2017 · AI

Single-Cell Transcriptional and Epigenomic Dissection to Identify Therapeutic Targets for ALS and FTD

$733,242
Manolis Kellis · Massachusetts Institute Of Technology · R01 · FY2023 · AG

Variant to gene mapping for Alzheimer's Disease

$733,237
Struan F A Grant · Children'S Hosp Of Philadelphia · R01 · FY2019 · AG

Thalamo-Cortical Plasticity: Sensory Denervation and Loss of Dopamine

$733,235
Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS

Modeling hyperactivity in neurological disease using patient-derived pluripotent stem cells

$733,227
Fred H Gage · University Of Pennsylvania · U19 · FY2020 · MH

Molecular Pathways of Innate Immunity and Substance Abuse in NeuroHIV

$733,223
Joao Filipe Inacio Mamede · Rush University Medical Center · R33 · FY2025 · DA

HIV-1 Infection In Fetal Brain Cell Cultures And Pediatric Aids Brain Tissue

$733,169
Eugene O. Major · Neurological Disorders And Stroke · Z01 · FY2007 · NS

Highly Specific ZFN-Based HSC Gene Editing Therapies Identified By In Vivo Barcode Nanoparticle Screens And Rationally Designed Mrna

$733,169
James Dahlman · Georgia Institute Of Technology · UG3 · FY2021 · TR

Lineage pathway differentiation of CNS progenitor cells

$733,169
Eugene O. Major · Neurological Disorders And Stroke · Z01 · FY2007 · NS

Tailoring of cellular mechanical microenvironments to rescue age-related impairments in bone regeneration

$733,122
Elise F Morgan · Boston University (Charles River Campus) · R01 · FY2023 · AG